Skip to main content
. Author manuscript; available in PMC: 2016 Nov 10.
Published in final edited form as: Osteoporos Int. 2010 Oct 22;22(6):1873–1883. doi: 10.1007/s00198-010-1445-5

Table 4.

Manitoba concordance in risk stratification for Canadian FRAX versus CAROC for 10-year major osteoporotic fracture

CAROC Canadian FRAX
Low (<10%) Moderate (10–20%) High (>20%) Total
All subjects
 Low (<10%) 20,857 (53) 889 (2) 0 (0) 21,746 (55)
 Moderate (10–20%) 2,028 (30) 9,894 (25) 364 (1) 12,286 (31)
 High (>20%) 5 (0) 1,497 (4) 4,069 (10) 5,571 (14)
 Total 22,890 (342) 12,280 (31) 4,433 (11) 39,603 (100)
 Concordance 34,820 (88)
No-risk factors
 Low (<10%) 20,857 (65) 889 (3) 0 (0) 21,746 (67)
 Moderate (10–20%) 704 (12) 7,684 (24) 306 (1) 8,694 (27)
 High (>20%) 0 (0) 350 (1) 1,464 (5) 1,814 (6)
 Total 21,561 (360) 8,923 (28) 1,770 (5) 32,254 (100)
 Concordance 30,005 (93)
One-risk factors
 Low (<10%) 0 (0) 0 (0) 0 (0) 0 (0)
 Moderate (10–20%) 1,325 (19) 2,927 (41) 170 (2) 4,422 (62)
 High (>20%) 0 (0) 375 (5) 2,310 (33) 2,685 (38)
 Total 1,325 (19) 3,302 (46) 2,480 (35) 7,107 (100)
 Concordance 5,237 (74)
Two-risk factors
 Low (<10%) 0 (0) 0 (0) 4 (2) 4 (2)
 Moderate (10–20%) 0 (0) 0 (0) 55 (23) 55 (23)
 High (>20%) 0 (0) 0 (0) 183 (76) 183 (76)
 Total 0 (0) 0 (0) 242 (100) 242 (100)
 Concordance 183 (76)

Results are stratified by the number of additional clinical risk factors (prior fragility fracture and prolonged glucocorticoid use)